There are different estimates out there, yet I read that global PD market is currently 7b USD growing to 13b by 2032 (say 9b by the time NUZ gets to market maturity) I interpret Kpax comment as NUZ001 being relevant to 20% of PD cases? Lets guess a % market share/penetration of 30%(??) 9b x 20% x 30% = 540m revenue PA at a conservative estimate. Using a middle of the road 6x multiplier we get around 3.2b valuation All very crude calcs, but one would hope success here would at minimum translate to 2b USD value for holders. From what I read, PD market seems to be around 10x size of ALS, yet I doubt we could do a direct extrapolation here from prior ALS valuations due to market dynamics. I recall NUZ valuations from various punters (including MT himself) ranging from 2b to 5b (say 2b) So we get: ALS 2b PD 2b Alzheimers ? Huntingtons ? Others ? Does the Platform Super Value Pack attract a discount or a premium?
NUZ Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)